Health & Nutrition

bg
Anne Wojcicki to buy back 23andMe and its data for $305 million

Anne Wojcicki to buy back 23andMe and its data for $305...

Anne Wojcicki to buy back 23andMe and its data for $305 million

bg
Quest Protein Ice Cream by Louis Gantus

Quest Protein Ice Cream by Louis Gantus

Mood for a Questified high protein ice cream using Quest Protein Milkshakes with...

bg
What About Elderberry, Echinacea, and Cranberries for Colds and the Flu? 

What About Elderberry, Echinacea, and Cranberries for Colds...

How effective are flu shots, elderberries, echinacea, and cranberries? The U.S....

bg
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

Healthy Returns: Ozempic, Wegovy linked to rare cases of...

Novo Nordisk's drugs are being linked to an eye condition that can cause vision...

bg
RFK Jr.'s firing of CDC vaccine panel undermines science, could threaten public health, experts say

RFK Jr.'s firing of CDC vaccine panel undermines science,...

Some experts say the move undermines science, disrupts a trusted regulatory process...

bg
What's next for Oura Ring in personal health and fitness monitoring, according to CEO Tom Hale

What's next for Oura Ring in personal health and fitness...

Oura has leaned further into providing wearers of its eponymous connected ring with...

bg
Skip the Salt and Shake on Potassium Chloride?

Skip the Salt and Shake on Potassium Chloride?

Worldwide, physical inactivity accounts for more than 10 million years of healthy...

bg
Omada Health prices IPO at $19 per share, in middle of expected range

Omada Health prices IPO at $19 per share, in middle of...

Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks...

bg
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

How twin sister triathletes doubled down on sports success...

Michal and Merav Mor, twin sister triathletes and PhDs, turned a quest for fitness...

bg
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

FDA approves Merck’s RSV shot for infants, ramping up competition...

Merck's shot will compete against a similar blockbuster treatment from Sanofi and...